Komori
Revision to earnings forecast4360MANAC Chemical Partners Co.,LtdMaterials and Chemicals

Notice of Variance between the FY2024 Earnings Forecast and Actual Results

Comparing the full-year forecast as of 29 March 2024 with actual results, revenue was broadly in line with the forecast. Operating and ordinary income were below forecast, while net income attributable to owners of the parent was above forecast due to a reduction in extraordinary losses.

Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
38.2
%
Wording
Definitive
How definitive the wording is.

Revised forecast

Fiscal year ending March 2024 · Full yearPrevious forecast published 2024年3月29日公表
Net Sales9,680→9,686million
+0.1%
Operating profit-70→-106million
-51.4%
Ordinary income10→-11million
-210.0%
Profit attributable to owners of the parent55→76million
+38.2%
Net income per share6.87→9.52yen and sen
+38.6%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

想定よりも売上原価が増加したことから営業利益及び経常利益は減少しました。一方、連結子会社の株式譲渡に係る特別損失額を精査した結果、損失額が減少し、親会社株主に帰属する当期純利益は増加しました。

Details and amount of extraordinary loss

連結子会社の株式譲渡に係る特別損失額が減少。具体的な金額はNot disclosed。

Previous-period results売上高11,853百万円、営業利益991百万円、経常利益1,179百万円、親会社株主に帰属する当期純利益821百万円、1株当たり当期純利益103.26円 銭(2023年3月期)
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥9,680 million → ¥9,686 million(+0.1%)
Operating profit¥-70 million → ¥-106 million
Ordinary income¥10 million → ¥-11 million
Profit attributable to owners of the parent¥55 million → ¥76 million(+38.2%)
Net income per share6.87 yen and sen → 9.52 yen and sen
Fiscal Period CoveredFiscal year ending March 2024
Period CoveredFull year
Publication date of previous forecast2024年3月29日公表
Previous-period results売上高11,853百万円、営業利益991百万円、経常利益1,179百万円、親会社株主に帰属する当期純利益821百万円、1株当たり当期純利益103.26円 銭(2023年3月期)
Reason for the revision想定よりも売上原価が増加したことから営業利益及び経常利益は減少しました。一方、連結子会社の株式譲渡に係る特別損失額を精査した結果、損失額が減少し、親会社株主に帰属する当期純利益は増加しました。
Details and amount of extraordinary loss連結子会社の株式譲渡に係る特別損失額が減少。具体的な金額はNot disclosed。
Consolidated / non-consolidatedConsolidated
Items this document does not state (1)
Dividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

想定より売上原価が増加したため営業利益と経常利益が減少しました。一方、連結子会社の株式譲渡に係る特別損失額を精査した結果、損失額が減少し、親会社株主に帰属する当期純利益が増加しました。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Variance between the FY2024 Earnings Forecast and Actual Results | MANAC Chemical Partners Co.,Ltd (4360) timely disclosure | Komori